Abstract
Endoscopic eradication therapy (EET) for dysplastic BE combines endoscopic resection and ablation to achieve complete remission of dysplasia (CRD) and complete remission of intestinal metaplasia (CRIM). Level 1 evidence supports the use of radiofrequency ablation (RFA) in reducing progression in BE-high grade dysplasia (HGD) and low-grade dysplasia (LGD). Efficacy of ablation using the Cryoballoon ablation (CBA) system has been demonstrated in a multicenter cohort study. Comparative outcome data between these two modalities are lacking. We aimed to assess the comparative effectiveness of these two ablation modalities in a multicenter cohort study.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
